These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32452362)

  • 1. [Therapeutic potential of ambroxol for motor neuron diseases].
    Bouscary A; Quessada C
    Med Sci (Paris); 2020 May; 36(5):447-448. PubMed ID: 32452362
    [No Abstract]   [Full Text] [Related]  

  • 2. [The time has come of a therapeutic (re)positioning of the ultra-rare diseases].
    Martinat C; Peschanski M
    Med Sci (Paris); 2018 Dec; 34(12):1019-1021. PubMed ID: 30623755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Organic cation transporters as novel therapeutic targets for depression].
    Gautron S; Pietranscosta N
    Med Sci (Paris); 2020; 36(8-9):703-705. PubMed ID: 32821044
    [No Abstract]   [Full Text] [Related]  

  • 4. [New hopes for the treatment of persistent Mycobacterium abscessus infections?].
    Raynaud C; Kremer L
    Med Sci (Paris); 2020; 36(8-9):691-694. PubMed ID: 32821041
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics.
    Talevi A; Bellera CL
    Expert Opin Drug Discov; 2020 Apr; 15(4):397-401. PubMed ID: 31847616
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of complex regional pain syndrome with topical ambroxol: a case series.
    Maihöfner C; Schneider S; Bialas P; Gockel H; Beer KG; Bartels M; Kern KU
    Pain Manag; 2018 Nov; 8(6):427-436. PubMed ID: 30394190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital myasthenic syndromes: repurposing does not simplify access de facto - Clinical use of innovative, repurposed or off-label therapies: a real life experience (4)].
    Eymard B
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():28-31. PubMed ID: 30943158
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease.
    Abe K; Morita S; Kikuchi T; Itoyama Y
    J Neurosci Res; 1997 Apr; 48(1):63-70. PubMed ID: 9086182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases].
    Plomer M; de Zeeuw J
    MMW Fortschr Med; 2017 Jun; 159(Suppl 5):22-33. PubMed ID: 28643291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases.
    Echaniz-Laguna A; Bousiges O; Loeffler JP; Boutillier AL
    Curr Med Chem; 2008; 15(13):1263-73. PubMed ID: 18537606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory properties of ambroxol.
    Beeh KM; Beier J; Esperester A; Paul LD
    Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The RARE 2017 meeting for companies developing products for rare patients].
    Ferry A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():7. PubMed ID: 29911542
    [No Abstract]   [Full Text] [Related]  

  • 15. Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets.
    Cipolat Mis MS; Brajkovic S; Frattini E; Di Fonzo A; Corti S
    Mol Cell Neurosci; 2016 Apr; 72():84-90. PubMed ID: 26837042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dexamethasone combined with ambroxol hydrochloride on T-Cell subsets and hearing in patients with secretory otitis media.
    Xiaorong D; Li M; Xuefeng L; Jian H
    Pak J Pharm Sci; 2019 May; 32(3 Special):1437-1440. PubMed ID: 31551228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
    Primbs K
    Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease.
    Zimran A; Altarescu G; Elstein D
    Blood Cells Mol Dis; 2013 Feb; 50(2):134-7. PubMed ID: 23085429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ambroxol in etiotropic chemotherapy of pulmonary tuberculosis].
    Suslov VA; Burtseva SA; Levchenko GI
    Voen Med Zh; 2002 May; 323(5):43-4. PubMed ID: 12073838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.